404 related articles for article (PubMed ID: 19432881)
21. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
22. Natural Killer Cell Sensing of Infected Cells Compensates for MyD88 Deficiency but Not IFN-I Activity in Resistance to Mouse Cytomegalovirus.
Cocita C; Guiton R; Bessou G; Chasson L; Boyron M; Crozat K; Dalod M
PLoS Pathog; 2015 May; 11(5):e1004897. PubMed ID: 25954804
[TBL] [Abstract][Full Text] [Related]
23. Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin.
Hayakawa Y; Kelly JM; Westwood JA; Darcy PK; Diefenbach A; Raulet D; Smyth MJ
J Immunol; 2002 Nov; 169(10):5377-81. PubMed ID: 12421908
[TBL] [Abstract][Full Text] [Related]
24. Enhanced tumor responses to dendritic cells in the absence of CD8-positive cells.
Ribas A; Wargo JA; Comin-Anduix B; Sanetti S; Schumacher LY; McLean C; Dissette VB; Glaspy JA; McBride WH; Butterfield LH; Economou JS
J Immunol; 2004 Apr; 172(8):4762-9. PubMed ID: 15067052
[TBL] [Abstract][Full Text] [Related]
25. IL-15 and type I interferon are required for activation of tumoricidal NK cells by virus-infected dendritic cells.
Boudreau JE; Stephenson KB; Wang F; Ashkar AA; Mossman KL; Lenz LL; Rosenthal KL; Bramson JL; Lichty BD; Wan Y
Cancer Res; 2011 Apr; 71(7):2497-506. PubMed ID: 21307131
[TBL] [Abstract][Full Text] [Related]
26. Dendritic cell-tumor coculturing vaccine can induce antitumor immunity through both NK and CTL interaction.
Kim KD; Choi SC; Kim A; Choe YK; Choe IS; Lim JS
Int Immunopharmacol; 2001 Nov; 1(12):2117-29. PubMed ID: 11710541
[TBL] [Abstract][Full Text] [Related]
27. Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination.
Kim A; Noh YW; Kim KD; Jang YS; Choe YK; Lim JS
Exp Mol Med; 2004 Oct; 36(5):428-43. PubMed ID: 15557815
[TBL] [Abstract][Full Text] [Related]
28. Toll-like receptor-dependent IL-12 production by dendritic cells is required for activation of natural killer cell-mediated Type-1 immunity induced by Chrysanthemum coronarium L.
Tanaka S; Koizumi S; Masuko K; Makiuchi N; Aoyagi Y; Quivy E; Mitamura R; Kano T; Ohkuri T; Wakita D; Chamoto K; Kitamura H; Nishimura T
Int Immunopharmacol; 2011 Feb; 11(2):226-32. PubMed ID: 21144920
[TBL] [Abstract][Full Text] [Related]
29. BCR/ABL promotes dendritic cell-mediated natural killer cell activation.
Terme M; Borg C; Guilhot F; Masurier C; Flament C; Wagner EF; Caillat-Zucman S; Bernheim A; Turhan AG; Caignard A; Zitvogel L
Cancer Res; 2005 Jul; 65(14):6409-17. PubMed ID: 16024645
[TBL] [Abstract][Full Text] [Related]
30. MyD88-dependent and -independent murine cytomegalovirus sensing for IFN-alpha release and initiation of immune responses in vivo.
Delale T; Paquin A; Asselin-Paturel C; Dalod M; Brizard G; Bates EE; Kastner P; Chan S; Akira S; Vicari A; Biron CA; Trinchieri G; Brière F
J Immunol; 2005 Nov; 175(10):6723-32. PubMed ID: 16272328
[TBL] [Abstract][Full Text] [Related]
31. B cell-intrinsic MyD88 signaling controls IFN-γ-mediated early IgG2c class switching in mice in response to a particulate adjuvant.
Lee MSJ; Natsume-Kitatani Y; Temizoz B; Fujita Y; Konishi A; Matsuda K; Igari Y; Tsukui T; Kobiyama K; Kuroda E; Onishi M; Marichal T; Ise W; Inoue T; Kurosaki T; Mizuguchi K; Akira S; Ishii KJ; Coban C
Eur J Immunol; 2019 Sep; 49(9):1433-1440. PubMed ID: 31087643
[TBL] [Abstract][Full Text] [Related]
32. Dendritic cells and NK cells stimulate bystander T cell activation in response to TLR agonists through secretion of IFN-alpha beta and IFN-gamma.
Kamath AT; Sheasby CE; Tough DF
J Immunol; 2005 Jan; 174(2):767-76. PubMed ID: 15634897
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant-mediated tumor regression and tumor-specific cytotoxic response are impaired in MyD88-deficient mice.
Akazawa T; Masuda H; Saeki Y; Matsumoto M; Takeda K; Tsujimura K; Kuzushima K; Takahashi T; Azuma I; Akira S; Toyoshima K; Seya T
Cancer Res; 2004 Jan; 64(2):757-64. PubMed ID: 14744795
[TBL] [Abstract][Full Text] [Related]
34. INAM plays a critical role in IFN-γ production by NK cells interacting with polyinosinic-polycytidylic acid-stimulated accessory cells.
Kasamatsu J; Azuma M; Oshiumi H; Morioka Y; Okabe M; Ebihara T; Matsumoto M; Seya T
J Immunol; 2014 Nov; 193(10):5199-207. PubMed ID: 25320282
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow-derived IFN-producing killer dendritic cells account for the tumoricidal activity of unpulsed dendritic cells.
Himoudi N; Nabarro S; Buddle J; Eddaoudi A; Thrasher AJ; Anderson J
J Immunol; 2008 Nov; 181(9):6654-63. PubMed ID: 18941256
[TBL] [Abstract][Full Text] [Related]
36. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
[TBL] [Abstract][Full Text] [Related]
37. Costimulation of multiple NK cell activation receptors by NKG2D.
Ho EL; Carayannopoulos LN; Poursine-Laurent J; Kinder J; Plougastel B; Smith HR; Yokoyama WM
J Immunol; 2002 Oct; 169(7):3667-75. PubMed ID: 12244159
[TBL] [Abstract][Full Text] [Related]
38. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice.
Nakagawa R; Nagafune I; Tazunoki Y; Ehara H; Tomura H; Iijima R; Motoki K; Kamishohara M; Seki S
J Immunol; 2001 Jun; 166(11):6578-84. PubMed ID: 11359810
[TBL] [Abstract][Full Text] [Related]
40. In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.
Konjević G; Mirjačić Martinović K; Vuletić A; Babović N
Melanoma Res; 2010 Dec; 20(6):459-67. PubMed ID: 20938360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
